Intellectual Ventures I LLC v. Capital One Fin. Corp.

Decision Date30 November 2017
Docket NumberCase No.: PWG–14–111
Citation280 F.Supp.3d 691
Parties INTELLECTUAL VENTURES I LLC, et al., Plaintiffs/Counter–Defendants, v. CAPITAL ONE FINANCIAL CORP., et al., Defendants/Counterclaimants/Third–Party Plaintiffs, v. Intellectual Ventures Management, LLC, et al., Third–Party Defendants/Joined Counter–Defendants.
CourtU.S. District Court — District of Maryland

Michael Edward McCabe, Jr., McCabe Law LLC, Potomac, MD, Bryan D. Bolton, Funk and Bolton PA, Baltimore, MD, Clayton Walter Thompson, II, David L. Alberti, Ian Neville Feinberg, Jeremiah Armstrong, Marc Belloli, Margaret Elizabeth Day, Nickolas Bohl, Sal Lim, Vinay Malik, Yakov Zolotorev, Feinberg Day Alverti and Thompson LLP, Menlo Park, CA, Daniel J. Weinberg, Jessica N. Leal, Rachel B. Kinney, Robert E. Freitas, Freitas Angel and Weinberg LLP, Redwood Shores, CA, David Taylor Rudolph, Eric B. Fastiff, Lieff Cabraser Heimann and Bernstein LLP, San Francisco, CA, for Plaintiffs/Counter–Defendants.

Mary Catherine Zinsner, Syed Mohsin Reza, Lesley Whitcomb Fierst, Troutman Sanders LLP, Tysons Corner, VA, Matthew Moore, Adam M. Greenfield, Gabriel K. Bell, Kerry J. Dingle, William H. Rawson, Latham & Watkins LLP, Washington, DC, Alicia R. Jovais, Christopher St. John Yates, Latham & Watkins LLP, San Francisco, CA, Christopher J. Forstner, Dabney J. Carr, IV, Megan C. Rahman, Robert A. Angle, Troutman Sanders LLP, Richmond, VA, Clement Naples, Daniel Anziska, Susan Grace, Troutman Sanders LLP, New York, NY, David W. Higer, Joel Merkin, Kenneth R. Adamo, Kristina Hendricks, Megan M. New, Ryan M. Hubbard, Vishesh Narayen, Brent P. Ray, Kirland and Ellis LLP, Kristopher Davis, Latham and Watkins, Chicago, IL, Jeffrey G. Homrig, Katherine M. Schon, Michelle Patricia Woodhouse, Patricia Young, Latham and Watkins LLP, Menlo Park, CA, Paul E. McGowan, Troutman Sanders LLP, Atlanta, GA, Andrew Jay Graham, Kramon and Graham PA, Baltimore, MD, for Defendants/Counterclaimants/Third–PartyPlaintiffs.

MEMORANDUM OPINION

Paul W. Grimm, United States District JudgeThe litigation history between the Intellectual Ventures companies (Plaintiffs, Counter–Defendants, Third–Party Defendants, and Joined Counter–Defendants to this action; collectively referred to as "IV") and the Capital One companies (Defendants, Counterclaimants, and Third–PartyPlaintiffs in this action; collectively referred to as "Capital One") is protracted, beginning with a patent infringement action that Intellectual Ventures I, LLC and Intellectual Ventures II, LLC(together, "IV I and II") filed in the Eastern District of Virginia on June 19, 2013.In that case, as well as in this patent infringement action that IV I and II filed on January 15, 2014, Capital One brought antitrust counterclaims.The Virginia court dismissed Capital One's antitrust claims for failure to state a claim, and IV now seeks summary judgment on very similar claims.ECF No. 656.Because NoerrPennington immunity and collateral estoppel both bar Capital One's antitrust claims, I will grant IV's motion.

Procedural Background

IV I and II filed suit in this Court, alleging that Capital One infringed five of their patents.Compl., ECF No. 1.IV I and II ultimately voluntarily withdrew one patent infringement claim and proceeded with the others.ECF Nos. 80, 81.The parties engaged in extensive discovery and agreed to referral to a Special Master highly experienced in patent law, jointly selected by the parties and appointed pursuant to Fed. R. Civ. P. 53.ECF Nos. 134, 136, 143.He oversaw additional discovery, following which the parties extensively briefed the patent infringement claims.ECF Nos. 147, 147–1, 169, 169–1, 227, 246, 297, 300, 303.

The Special Master issued two reports and recommendations, ECF Nos. 298 and 315, in which he ruled in favor of IV with respect to two of its patents, United States PatentNos. 7,984,081 and 6,546,002("the '081 Patent" and "the '002 Patent"), and in favor of Capital One on the claims related to United States PatentNos. 6,314,409 and 6,715,084("the '409 Patent" and "the '084 Patent").Both parties challenged the Special Master's rulings adverse to them, and further briefing ensued.ECF Nos. 307, 311, 312, 313, 319, 324, 325, 330, 335, 336, 344.

After reviewing the Special Master's reports and recommendations and the parties' extensive briefs, I overruled the Special Master with respect to the '081 Patent and the '002 Patent, finding that they were unenforceable.ECF Nos. 377, 378.I also ruled that collateral estoppel applied regarding the '409 Patent and the '084 Patent, barring IV from bringing claims against Capital One for infringement of those patents.ECF No. 382.The net effect of my ruling was that each of the patents that IV claimed Capital One had infringed was unenforceable, two patents because I concluded that they were invalid pursuant to 35 U.S.C. § 101, and two patents because the United States District Court for the Southern District of New York in IntellectualVentures v. JPMC , Case No. 13-3777-AKH, 2015 WL 1941331(S.D.N.Y.Apr. 28, 2015), concluded that they were invalid, and issue preclusion barred me from reaching a different conclusion.On those grounds, I entered summary judgment in Capital One's favor on those four remaining patent infringement claims.ECF Nos. 378, 382.And, finding no just reason for delay, I entered a final judgment in favor of Capital One on the patent infringement claims, making that order immediately appealable.ECF No. 387.The Federal Circuit affirmed my rulings, Intellectual Ventures I LLC v. Capital One Fin. Corp. , 850 F.3d 1332(Fed. Cir.2017), thereby ending the patent infringement claims against Capital One.

Meanwhile, Capital One had sought leave to file three antitrust counterclaims, claiming monopolization and attempted monopolization, in violation of Section 2 of the Sherman Act,15 U.S.C. § 2, and unlawful asset acquisition, in violation of Section 7 of the Clayton Act,15 U.S.C. § 18, as part of its Third Amended Answer, Defenses, and Counterclaims.ECF No. 106.IV I and II opposed the motion.ECF No. 118.I granted Capital One leave to file its counterclaims, ECF Nos. 194, 195, which it did, ECF No. 196;see alsoFourth Amended Answer, Defenses, and Counterclaims, ECF Nos. 438(redacted), 439 (sealed).It also filed a Third Party Complaint against additional Intellectual Ventures companies: Invention Investment Fund II, LLC; Intellectual Ventures Management, LLC;Invention Investment Fund I, L.P. ECF Nos. 228(sealed), 230 (redacted).Capital One alleges that IV has tried, without success, to license to Capital One its extensive patent portfolio, which includes the patents that IV has sued Capital One, in this suit and the Virginia suit, for infringing.Capital One believes that IV's repeated claims against it are actionable under antitrust law.

I denied IV's motions to dismiss the counterclaims and Third Party Complaint, ECF Nos. 225, 296, finding that Capital One had pled them sufficiently to proceed to discovery.ECF No. 328.After another round of extensive (and expensive) discovery regarding liability on the antitrust counterclaims, I attended a tutorial involving the economic experts that the parties had identified.ECF No. 651.Also in attendance was the court technical advisor, Professor John M. de Figueiredo of Duke University Law and Business Schools, whose appointment the parties had confirmed on a status conference call, and who assisted the court in evaluating the economic evidence.ECF Nos. 606, 608.1At the close of discovery, IV filed the pending Motion for Summary Judgment, which the parties fully briefed.2In support of their positions, the parties jointly submitted a 13,344 page Joint Record, comprising 286 exhibits in sixteen, 3–inch binders.Having reviewed the parties' memoranda and exhibits, I now rule.

Parties' Arguments

The essence of Capital One's antitrust claim is that IV is a "patent troll,"3 and not just any patent troll, but a veritable Dovregubben.4Capital One asserts that IV's business practice is to acquire a vast portfolio of thousands of patents that purportedly deal with technology essential to the types of services offered by commercial banks (such as ATM transactions, mobile banking, on-line banking, and credit card transactions).It then employs an aggressive marketing scheme whereby it makes an "offer" for banks to license (Capital One really would prefer to say "extorts" banks to license) its entire portfolio for a period of years at a jaw-droppingly high price.But, Capital One insists, when the banks ask for details about the patents covered in the portfolio in order to determine whether their services infringe them, IV refuses to disclose sufficient information to enable them to make an intelligent decision about whether they should agree to the license.And, if the bank balks at licensing the entire portfolio at IV's take-it-or-leave-it price, IV then threatens to file a patent infringement claim against the bank regarding only a few of the patents in the portfolio.Adding insult to injury, IV then makes it clear that should it lose the patent infringement case, it will simply file another (and if needed, another, and so on) regarding a different set of its patents, until the prospect of endless high-cost litigation forces the bank to capitulate and license the entire portfolio.5

Capital One characterizes IV's business model as comprised of three components:

accumulate a vast portfolio of patents purportedly relating to essential commercial banking services, conceal the details of those patents so that the banks cannot determine whether their products infringe any of IV's patents, and serially litigate to force the banks to capitulate and license the portfolio at exorbitant cost.This conduct, Capital One insists, constitutes monopolization under § 2 of the Sherman Act,15 U.S.C. § 2, attempted monopolization under § 2 of the Sherman Act, and...

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex
9 cases
  • Campbell v. Pa. Sch. Boards Ass'n
    • United States
    • U.S. Court of Appeals — Third Circuit
    • August 27, 2020
    ...burden [is] on the patent challenger to prove invalidity by clear and convincing evidence ..."); Intell. Ventures I LLC v. Capital One Fin. Corp. , 280 F. Supp. 3d 691, 708 (D. Md. 2017) (finding that the "exception to Noerr – Pennington immunity is narrow, ‘[g]iven the presumption of paten......
  • Wimbish v. Garten
    • United States
    • U.S. District Court — District of Maryland
    • January 24, 2020
    ...or fact had a full and fair opportunity to litigate the issue or fact in the prior proceeding." Intellectual Ventures I LLC v. Capital One Fin. Corp., 280 F. Supp. 3d 691, 716 (D. Md. 2017) (quoting In re Microsoft Corp. Antitrust Litig., 355 F.3d 322, 326 (4th Cir. 2004)). The doctrine is ......
  • Intellectual Ventures I LLC v. Capital One Fin. Corp.
    • United States
    • U.S. Court of Appeals — Federal Circuit
    • September 10, 2019
    ...the court subsequently granted summary judgment against Capital One on all the antitrust claims. Intellectual Ventures I LLC v. Capital One Fin. Corp. , 280 F. Supp. 3d 691 (D. Md. 2017). We affirm.IAIn the Virginia case, IV asserted five patents against Capital One. After the plaintiffs dr......
  • In re Marriott Int'l, Inc., Customer Data Sec. Breach Litig.
    • United States
    • U.S. District Court — District of Maryland
    • May 3, 2022
    ...F.3d 572, 590 (9th Cir. 2000) ; Reilly v. United States , 863 F.2d 149, 156 (1st Cir. 1988) ; Intellectual Ventures I LLC v. Capital One Fin. Corp. , 280 F. Supp. 3d 691, 695 n.1 (D. Md. 2017), aff'd , 937 F.3d 1359 (Fed. Cir. 2019). The parties agreed, and Dr. de Figueiredo provided invalu......
  • Get Started for Free
4 books & journal articles
  • Antitrust Issues in Litigating Intellectual Property
    • United States
    • ABA Antitrust Library Antitrust Issues in Intellectual Property Law. Second edition
    • May 7, 2024
    ...v. Implant Innovations, Inc., 141 F.3d 1059, 1068 (Fed. Cir. 1998)); see also Intellectual Ventures I LLC v. Capital One Fin. Corp., 280 F. Supp. 3d 691, 712 (D. Md. 2017). 78. Apotex Inc. v. Senju Pharm. Co . , 921 F. Supp. 2d 308 (D. Del. 2013). 79. Id. at 315. van53858_complete.indb 121 ......
  • Appendix B. Topical Index of Cases
    • United States
    • ABA Antitrust Library Antitrust Issues in Intellectual Property Law. Second edition
    • May 7, 2024
    ...Pharms., Inc. , ___ F. Supp. 3d ___, 2022 WL 289384 (N.D.N.Y. Jan. 31, 2022); Intellectual Ventures I LLC v. Capital One Fin. Corp ., 280 F. Supp. 3d 691 (D. Md. 2017) 4.8 Bifurcation Apotex Inc. v. Senju Pharmaceutical Co. , 921 F. Supp. 2d 308 (D. Del. 2013); Cascades Computer Innovation ......
  • Appendix C. Table of Authorities
    • United States
    • ABA Antitrust Library Antitrust Issues in Intellectual Property Law. Second edition
    • May 7, 2024
    ...et al., No. PWG- 14-111, 2015 WL 898146 (D. Md. Mar. 2, 2015), 147, 148, 149 Intellectual Ventures I LLC v. Capital One Fin. Corp., 280 F. Supp. 3d 691 (D. Md. 2017), 121 Intellectual Ventures LLC et al. v. Symantec Corp., 2014 WL 4773954 (D. Del. 2014), 83 Intergraph Corp. v. Intel Corp., ......
  • Antitrust Issues Involving Intellectual Property
    • United States
    • ABA Antitrust Library Antitrust Law Developments (Ninth Edition) - Volume II
    • February 2, 2022
    ...Labs, Inc. v. 10X Genomics, Inc., 483 F. Supp. 3d 38, 57 (D. Mass. 2020); Intellectual Ventures I LLC v. Capital One Fin. Corp., 280 F. Supp. 3d 691, 700 (D. Md. 2017); Business Review Letter by the Department of Justice, Antitrust Division, to Mark H. Hamer (July 28, 2020) at 8 n.53, avail......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT